查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2004752

固定式和可携式C型臂市场：便携性、应用、最终用户和销售管道划分－2026-2032年全球市场预测

Fixed & Mobile C-arms Market by Mobility, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，固定式和移动式 C 型臂市场价值将达到 29.2 亿美元，到 2026 年将成长到 31.2 亿美元，到 2032 年将达到 44.2 亿美元，复合年增长率为 6.07%。

主要市场统计数据
基准年 2025 29.2亿美元
预计年份：2026年 31.2亿美元
预测年份 2032 44.2亿美元
复合年增长率 (%) 6.07%

一个全面的框架，用于说明成像性能、移动特性和互通性要求如何重新定义临床环境中的采购和部署选择。

固定式和移动式C臂系统在现代外科手术中继续发挥核心作用，可在广泛的外科和介入领域实现即时影像诊断。本报告从技术整合、临床应用多样化和采购行为变化观点分析了市场。随着医疗系统优先发展微创手术，影像导引平台已成为临床路径中不可或缺的一部分，临床医生和采购委员会目前正在从解析度、剂量管理、工作流程整合和易用性等方面评估C臂的性能。

人工智慧影像处理、模组化设计以及医疗服务场所的转变如何重塑 C 型臂系统的采购重点和竞争地位。

C型臂系统的市场环境正经历变革性的转变，这主要得益于技术进步、临床路径的演进以及医疗服务体系的结构性转变。人工智慧和先进的影像处理演算法正在改善术中可视化效果，使临床医生能够更精准地进行手术，并有望缩短透视时间。此外，系统设计的模组化和以软体为中心的升级方式，使得医疗机构能够透过定期的功能增强来延长现有设备的使用寿命，而无需更换整个系统。

我们将评估累积关税措施如何改变了我们整个医疗影像设备产品组合的供应链经济、采购行为和策略采购决策。

美国于2025年实施的关税措施的累积影响波及C型臂系统的整个供应链、采购惯例和定价策略。对医疗设备零件和成品征收关税增加了依赖国际製造和复杂全球采购的产品的采购成本。为此，製造商正在考虑一系列战术性应对措施，包括将成本转嫁给买家、暂时自行承担部分利润以维持竞争力，或审查供应商合约并更换关键零件的来源。

详细的細項分析表明，临床应用、最终用户类型、行动性差异和销售管道如何共同决定差异化的商业性方法。

了解市场区隔对于制定有针对性的商业策略和产品蓝图至关重要。根据应用领域，临床需求多种多样，例如，心血管手术需要介入心臟病学和血管外科中独特的成像人体工程学和透视功能；牙科手术具有独特的成像几何结构；胃肠病学手术优先考虑与内镜工作流程的兼容性；神经外科、关节重组、脊柱手术和创伤手术对精度和图像融合要求极高，每种剂量泌尿系统都需要不同的视野和手术手术也将定位不同的手术

区域市场动态和策略重点决定了产品设计选择、监管应对措施以及在全球医疗保健生态系统中的服务部署。

区域趋势对产品设计、监管策略和市场拓展计画有显着影响。在美洲，医疗系统优先考虑整合式诊疗路径、先进的影像技术和完善的售后服务网络。同时，健保报销环境以及公立和私立医院的结构也影响着采购週期和资金筹措偏好。因此，供应商优先考虑的是完善的服务部署、临床证据的累积以及与关键医疗中心的合作，以加速产品部署。

为什么技术创新、广泛的服务生态系统和策略性经销伙伴决定了竞争优势和商业性发展动能？

C型臂领域的竞争动态仍有利于那些兼具技术领先地位、广泛服务网络和灵活经营模式的公司。业界领导企业透过提供支援高级引导、直觉式使用者介面和强大剂量管理的整合式成像平台脱颖而出。持续投资于软体更新和模组化硬体选项的公司，透过实现无需系统全面更换即可逐步增强功能，从而加强了与客户的关係。同时，拥有良好业绩记录的公司能够提供符合医院营运目标的远距离诊断，并具备快速部署、预防性保养计划和最大限度减少停机时间的优势。

为高阶主管提供的实用指南，内容涵盖如何增强产品韧性、实现供应链多元化、提高商业性柔软性以及加速临床部署。

产业领导者若想将不断变化的需求模式转化为商机，应采取一系列切实可行的优先事项，以平衡短期韧性和长期差异化优势。首先，调整产品蓝图，以满足多样化的用户需求，同时透过优先考虑模组化、软体可升级性和剂量优化功能来实现规模经济，这些功能预计将在多个临床专科领域中广泛应用。其次，透过多元化组件采购和实施短期紧急应变计画来增强供应链韧性。同时，考虑对关键子系统进行选择性近岸外包，以降低关税风险和前置作业时间波动的影响。

采用严谨的混合方法，结合临床医生的见解、采购情报、技术基准测试和咨询检验，确保获得可操作的见解。

本分析的调查方法结合了定性和定量方法，以确保得出严谨且切实可行的见解。主要研究工作包括对具有代表性的群体进行深度访谈，这些群体包括临床负责人、采购负责人和行业高管，旨在收集有关采购标准、营运限制和未满足的临床需求的第一手资讯。这些一手资讯与来自监管文件、临床文献、医疗设备使用说明书和公共采购记录的二手资讯相结合，以检验观察到的趋势，并从多个角度协调相关人员的观点。

整合市场动态，展现技术优势、供应链敏捷性和以客户为中心的服务模式如何创造永续的竞争优势。

总之，由于技术进步、医疗服务模式的变革以及采购压力的增加，C型臂市场正处于转折点。那些投资于模组化、以软体为中心的平台、强化服务和分销网络并展现出清晰的临床和经济价值的供应商，将更有利于把握各种临床应用和区域市场的机会。同时，关税和供应链中断等外部因素进一步凸显了策略采购和灵活商业性提案的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依移动性分類的固定式和可携式C型臂市场

  • 固定的
  • 活动

第九章 固定式和可携式C型臂市场：按应用领域划分

  • 心血管外科
    • 介入性心臟病学
    • 血管外科
  • 牙科手术
  • 胃肠病学
  • 神经外科
  • 整形外科
    • 关节重组
    • 脊椎手术
    • 创伤外科
  • 泌尿系统

第十章 固定式和可携式C型臂市场：按最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院
    • 私立医院
    • 公立医院

第十一章 固定式和可携式C型臂市场：依销售管道划分

  • 离线
  • 在线的

第十二章 固定式和可携式C型臂市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 固定式与可携式C臂市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 固定式和可携式C型臂市场：按国家/地区划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国固定式和可携式C型臂市场

第十六章：中国固定式与可携式C臂市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agfa-Gevaert Group（Agfa Healthcare）
  • Allengers Medical Systems
  • BPL Medical Technologies
  • Canon Medical Systems Corporation
  • Carestream Health
  • DMS Imaging（DMS Group）
  • Eurocolumbus Srl
  • FUJIFILM Holdings Corporation
  • GE HealthCare
  • Genoray Co. Ltd.
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Medtronic
  • OrthoScan, Inc.
  • Shimadzu Corporation
  • Siemens Healthineers
  • Skanray Technologies
  • SternMed GmbH
  • Trivitron Healthcare
  • Ziehm Imaging GmbH
Product Code: MRR-742BD517E39C

The Fixed & Mobile C-arms Market was valued at USD 2.92 billion in 2025 and is projected to grow to USD 3.12 billion in 2026, with a CAGR of 6.07%, reaching USD 4.42 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.92 billion
Estimated Year [2026] USD 3.12 billion
Forecast Year [2032] USD 4.42 billion
CAGR (%) 6.07%

A comprehensive framing of how imaging performance, mobility profiles, and interoperability requirements are redefining clinical procurement and adoption choices

Fixed and mobile C-arm systems remain central to modern procedural medicine, enabling real-time imaging across a broad set of surgical and interventional disciplines. The introduction frames the market through the lens of technological integration, care-site diversification, and shifting procurement behaviors. As health systems prioritize minimally invasive procedures, image-guidance platforms become integral to clinical pathways, leading clinicians and purchasing committees to evaluate C-arm performance across resolution, dose management, workflow integration, and ease of use.

Moreover, the introduction contextualizes how different mobility profiles-fixed installations for hybrid operating rooms and mobile units for procedure suites and ambulatory settings-respond to distinct clinical and operational requirements. Interoperability with electronic health records, compatibility with advanced imaging and navigation systems, and support for remote diagnostic workflows have risen in importance. Consequently, stakeholders are balancing capital allocation with operational considerations such as maintenance contracts, uptime guarantees, and staff training.

Transitioning from clinical utility to market dynamics, the intro highlights the convergence of clinical demand and supplier innovation. Regulatory expectations, heightened focus on patient safety, and a growing emphasis on radiation dose reduction are shaping procurement criteria. In sum, this opening sets an evidence-based stage for more detailed analysis of structural shifts, policy impacts, and segmentation-driven strategies that follow in the subsequent sections.

How advances in AI-driven imaging, modular design, and care-site migration are reshaping procurement priorities and competitive positioning for C-arm systems

The landscape for C-arm systems is undergoing transformative shifts driven by technological advances, evolving clinical pathways, and structural changes in care delivery. Artificial intelligence and enhanced image processing algorithms are improving intraoperative visualization, enabling clinicians to operate with greater precision while potentially reducing fluoroscopy time. Furthermore, modularity in system design and software-centric upgrades allow providers to extend the useful life of installed equipment through periodic feature enhancements rather than full system replacements.

At the same time, care is migrating out of traditional inpatient settings into ambulatory surgical centers and specialty clinics, prompting demand for compact mobile units that balance image quality with portability. As a result, manufacturers are tuning product lines to support a broader range of clinical environments, emphasizing rapid setup, small footprints, and simplified user interfaces. Payment models and procurement strategies are also shifting; hospitals and clinics increasingly evaluate total cost of ownership, vendor service networks, and financing options, which impacts adoption timelines and replacement cycles.

Supply chain resilience is another major element reshaping the market. Manufacturers are pursuing diversified sourcing, near-shoring of critical components, and closer vendor collaboration to mitigate disruptions. In parallel, regulatory scrutiny around device interoperability, cybersecurity, and radiation safety has intensified, encouraging suppliers to embed compliance and security-by-design principles into their development roadmaps. Taken together, these forces are producing a more competitive, innovation-driven environment where clinical value, operational flexibility, and strategic supply continuity determine market leadership.

Evaluating how cumulative tariff measures have altered supply chain economics, procurement behavior, and strategic sourcing decisions across imaging equipment portfolios

The cumulative impact of tariff actions implemented by the United States in 2025 reverberates across the supply chain, procurement practices, and pricing strategies for C-arm systems. Tariffs on medical device components and finished units increase landed costs for products that rely on international manufacturing and complex global sourcing. In response, manufacturers evaluate a spectrum of tactical and strategic responses that include passing costs through to buyers, absorbing margins temporarily to retain competitive positioning, or restructuring supplier agreements to relocate critical component sourcing.

Operationally, hospitals and ambulatory centers confront heightened budgetary scrutiny as procurement committees reassess capital projects in light of increased acquisition costs. Consequently, capital planning cycles may lengthen and vendors may be required to provide more flexible financing, extended service agreements, or bundled consumable offerings to preserve procurement momentum. Additionally, higher import costs can accelerate conversations around localization and near-shoring; however, shifting production footprints entails lead times and capital investment that temper immediate migration.

From a strategic perspective, tariffs also provoke renewed emphasis on value engineering and product differentiation. Vendors are incentivized to develop offerings that emphasize lifecycle cost reductions through lower maintenance requirements, software-driven functionality upgrades, and energy efficiency. Meanwhile, health systems may seek multi-supplier strategies and framework agreements to distribute procurement risk. Ultimately, the 2025 tariff landscape makes supply chain transparency, contractual flexibility, and demonstrated total cost benefits decisive factors in commercial negotiations.

Deep segmentation intelligence showing how clinical applications, end-user types, mobility distinctions, and sales channels jointly define differentiated commercial approaches

Understanding segmentation is essential for crafting targeted commercial strategies and product roadmaps. Based on application, clinical demand spans specialties such as cardiovascular surgery, where interventional cardiology and vascular surgery require distinct imaging ergonomics and fluoroscopic performance, dental surgery with its specific imaging geometries, gastroenterology procedures that prioritize compatibility with endoscopic workflows, neurosurgery where precision and image fusion capabilities are paramount, orthopedic surgery which includes joint reconstruction, spinal surgery, and trauma surgery each with differing field-of-view and imaging mobility requirements, and urology where flexible positioning and dose management influence buying criteria.

Based on end user, purchasing behaviors and operating constraints vary between ambulatory surgical centers, clinics, and hospitals, with hospitals themselves representing private and public institutions that follow different procurement protocols, budget cycles, and regulatory oversight. These distinctions influence not only the preferred mobility solutions but also the level of service support and uptime commitments required. Based on mobility, the market differentiates fixed systems-typically installed in hybrid ORs and optimized for high-end surgical suites-from mobile units that support procedure rooms, outreach clinics, and point-of-care imaging needs, each driving unique installation and workflow considerations.

Finally, based on sales channel, engagement strategies differ between direct sales models and distributor-led approaches. Direct sales often facilitate deeper clinical relationships and bundled contracting, whereas distributor channels, which encompass e-commerce and value-added resellers, extend geographic reach and provide local logistics, installation, and service capabilities. Synthesizing these segmentation lenses reveals that effective commercialization requires aligning product attributes, service models, and channel incentives with the specific clinical, operational, and procurement realities of each buyer cohort.

Regional market dynamics and strategic priorities that determine product design choices, regulatory pathways, and service footprints across global healthcare ecosystems

Regional dynamics exert distinct influences on product design, regulatory strategy, and go-to-market planning. In the Americas, health systems emphasize integrated care pathways, advanced imaging capabilities, and strong aftersales service networks, while reimbursement environments and private versus public hospital structures shape procurement cycles and financing preferences. Consequently, suppliers prioritize robust service footprints, clinical evidence generation, and partnerships with leading medical centers to accelerate adoption.

Across Europe, Middle East & Africa, the regulatory mosaic and diverse payer structures require adaptive strategies that balance centralized approvals with country-level market access planning. Procurement practices in these regions may favor public tendering and consortium purchasing in certain markets, which elevates the importance of competitively priced, reliable systems and cost-of-ownership narratives. Meanwhile, the Middle Eastern markets often show accelerated capital investment in advanced hybrid ORs, creating opportunities for fixed systems paired with comprehensive service contracts. In Africa, infrastructure constraints can increase demand for rugged, energy-efficient mobile solutions.

In the Asia-Pacific region, rapid expansion of ambulatory services, rising procedure volumes, and substantial investments in hospital modernization drive demand across both fixed and mobile categories. Diverse maturity levels among healthcare markets mean suppliers must offer a spectrum of solutions, from premium integrated systems for advanced medical centers to cost-effective, high-value units tailored for emerging markets. Across all regions, successful market entry depends on localized clinical education, regulatory alignment, and distribution partnerships that reflect regional operational realities.

Why technological innovation, expansive service ecosystems, and strategic distribution partnerships will determine competitive advantage and commercial momentum

Competitive dynamics in the C-arm space continue to favor companies that combine technological leadership with expansive service networks and flexible commercial models. Leaders differentiate by offering integrated imaging platforms that support advanced guidance, intuitive user interfaces, and robust dose management. Firms investing in continuous software updates and modular hardware options create stickiness with customers by enabling incremental capability enhancements without full-system replacement. At the same time, companies with deep installation footprints can deliver rapid deployment, preventive maintenance programs, and remote diagnostics that minimize downtime and align with hospital operational goals.

Additionally, strategic partnerships and alliances-both with clinical centers and with software or navigation providers-are shaping competitive advantage. Organizations that cultivate clinical evidence through peer-reviewed studies and real-world use cases strengthen buyer confidence and accelerate adoption in specialized procedures. Distribution strategy also remains a differentiator: direct sales channels offer closer clinical engagement and value-based contracting, whereas distributor networks expand reach in regions where local logistics and service capability are paramount.

Finally, smaller innovative firms continue to influence the market by introducing niche technologies, such as compact mobile units optimized for ambulatory settings or AI-enabled reconstruction techniques that enhance image clarity. These entrants force incumbents to respond through targeted product enhancements, strategic acquisitions, or reshaped pricing models. The net effect is a market where technological differentiation, service quality, and channel strategy determine competitive positioning and commercial traction.

A practical playbook for executives to strengthen product resilience, diversify supply chains, expand commercial flexibility, and accelerate clinical adoption

Industry leaders seeking to capitalize on shifting demand patterns should adopt a set of actionable priorities that balance short-term resilience with long-term differentiation. First, align product roadmaps to prioritize modularity, software-upgradability, and dose optimization features that resonate across multiple clinical specialties, thereby achieving economies of scale while addressing diverse user needs. Next, strengthen supply chain resilience by diversifying component sourcing and implementing near-term contingency plans; at the same time, evaluate selective near-shoring for critical subsystems to reduce tariff exposure and lead-time volatility.

Simultaneously, refine commercial models by offering financing options, performance-based warranties, and bundled service agreements that ease capital constraints and emphasize total lifecycle value. Invest in outcomes-focused clinical studies and targeted training programs to accelerate clinician adoption and demonstrate measurable improvements in workflow efficiency and patient safety. Expand channel flexibility by combining direct sales expertise with selective distributor partnerships, including e-commerce and value-added resellers where appropriate, to broaden geographic reach without diluting clinical support quality.

Lastly, embed regulatory and cybersecurity considerations early into product development to reduce time-to-market risk and differentiate on compliance. By executing these recommendations in a coordinated manner, leaders can create defensible positions that mitigate near-term external pressures while building capabilities that translate into sustained commercial growth.

A rigorous mixed-methods approach combining clinician insights, procurement intelligence, technical benchmarking, and advisory validation to ensure actionable findings

The research methodology underpinning this analysis combines qualitative and quantitative approaches to ensure rigorous, actionable findings. Primary research involved in-depth interviews with a representative cross-section of clinical leaders, procurement officers, and industry executives to capture firsthand insights into buying criteria, operational constraints, and unmet clinical needs. These primary inputs were synthesized with secondary intelligence drawn from regulatory filings, clinical literature, device instructions for use, and public procurement records to validate observed trends and triangulate stakeholder perspectives.

Analytical techniques included comparative feature benchmarking across device classes, assessment of service and maintenance models, and scenario analysis to explore the implications of policy changes such as tariff adjustments. Where appropriate, supplier product portfolios were evaluated for modular upgrade pathways, interoperability features, and software support models. The methodology emphasized transparency in assumptions and traceability of sources, and each major conclusion is grounded in multiple lines of evidence.

Finally, findings were reviewed by an external advisory panel of clinicians and procurement specialists to ensure clinical relevance and practical applicability. This mixed-methods approach delivers balanced insights that are both strategically meaningful for executives and operationally actionable for commercial teams.

A synthesis of market dynamics showing how technical excellence, supply chain agility, and customer-focused service models create sustainable competitive advantage

In conclusion, the C-arm market is at an inflection point driven by technological advancement, changing care delivery models, and evolving procurement pressures. Suppliers that invest in modular, software-centric platforms, strengthen their service and distribution footprints, and demonstrate clear clinical and economic value will be best positioned to capture opportunities across a diverse set of clinical applications and regional markets. Meanwhile, external factors such as tariff actions and supply chain disruptions have heightened the importance of strategic sourcing and flexible commercial offerings.

Looking ahead, successful organizations will integrate clinical evidence generation with adaptive commercial models that reflect localized payer and institutional dynamics. By doing so, they can reduce adoption friction, shorten procurement cycles, and create deeper customer relationships that extend beyond initial equipment sales. Collaboration across industry partners, health systems, and regulatory bodies will also be essential to advance interoperability, safety, and clinician training. Overall, the market rewards those who combine technical excellence with operational agility and customer-centric service models.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Fixed & Mobile C-arms Market, by Mobility

  • 8.1. Fixed
  • 8.2. Mobile

9. Fixed & Mobile C-arms Market, by Application

  • 9.1. Cardiovascular Surgery
    • 9.1.1. Interventional Cardiology
    • 9.1.2. Vascular Surgery
  • 9.2. Dental Surgery
  • 9.3. Gastroenterology
  • 9.4. Neurosurgery
  • 9.5. Orthopedic Surgery
    • 9.5.1. Joint Reconstruction
    • 9.5.2. Spinal Surgery
    • 9.5.3. Trauma Surgery
  • 9.6. Urology

10. Fixed & Mobile C-arms Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals
    • 10.3.1. Private Hospitals
    • 10.3.2. Public Hospitals

11. Fixed & Mobile C-arms Market, by Sales Channel

  • 11.1. Offline
  • 11.2. Online

12. Fixed & Mobile C-arms Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Fixed & Mobile C-arms Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Fixed & Mobile C-arms Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Fixed & Mobile C-arms Market

16. China Fixed & Mobile C-arms Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agfa-Gevaert Group (Agfa Healthcare)
  • 17.6. Allengers Medical Systems
  • 17.7. BPL Medical Technologies
  • 17.8. Canon Medical Systems Corporation
  • 17.9. Carestream Health
  • 17.10. DMS Imaging (DMS Group)
  • 17.11. Eurocolumbus Srl
  • 17.12. FUJIFILM Holdings Corporation
  • 17.13. GE HealthCare
  • 17.14. Genoray Co. Ltd.
  • 17.15. Hologic, Inc.
  • 17.16. Koninklijke Philips N.V.
  • 17.17. Medtronic
  • 17.18. OrthoScan, Inc.
  • 17.19. Shimadzu Corporation
  • 17.20. Siemens Healthineers
  • 17.21. Skanray Technologies
  • 17.22. SternMed GmbH
  • 17.23. Trivitron Healthcare
  • 17.24. Ziehm Imaging GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FIXED & MOBILE C-ARMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FIXED & MOBILE C-ARMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES FIXED & MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA FIXED & MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY FIXED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY FIXED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY VASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY VASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY DENTAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY DENTAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY DENTAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY JOINT RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY JOINT RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY SPINAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY SPINAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY TRAUMA SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY TRAUMA SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY TRAUMA SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS FIXED & MOBILE C-ARMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. GCC FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 145. GCC FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. GCC FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 148. GCC FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. GCC FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 150. GCC FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. G7 FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 169. G7 FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. G7 FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 172. G7 FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. G7 FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 174. G7 FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. NATO FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 177. NATO FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. NATO FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 180. NATO FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. NATO FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 182. NATO FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL FIXED & MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES FIXED & MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA FIXED & MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA FIXED & MOBILE C-ARMS MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA FIXED & MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA FIXED & MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA FIXED & MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA FIXED & MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA FIXED & MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA FIXED & MOBILE C-ARMS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)